DA Berry
Impact in
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 3
- Cancer Genomics and Diagnostics 3
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 1
DA Berry
7 papers receiving 658 citations
DA Berry's Hit Papers
Peers
Comparison fields: 5 of 72
- Statistics and Probability 224
- Cancer Research 283
- Oncology 183
- Management Science and Operations Research 55
- Economics and Econometrics 92
Countries citing papers authored by DA Berry
This map shows the geographic impact of DA Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DA Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DA Berry more than expected).
Fields of papers citing papers by DA Berry
This network shows the impact of papers produced by DA Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DA Berry. The network helps show where DA Berry may publish in the future.
Co-authors
The 25 scholars most cited alongside DA Berry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy Hit paper breakdown → | 2009 | 534 |
| 2 | 2016 | 58 | |
| 3 | 2013 | 39 | |
| 4 | 2015 | 35 | |
| 5 | 2015 | 23 | |
| 6 | 2017 | 1 | |
| 7 | 2017 | 1 |
About DA Berry
DA Berry is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics and Statistics and Probability, having authored 7 papers that have together received 691 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Cancer Genomics and Diagnostics (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Statistical Methods in Clinical Trials (2 papers), Cancer Treatment and Pharmacology (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Genomics and Rare Diseases (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Statistics and Probability (224 citations), Cancer Research (283 citations), Oncology (183 citations), Management Science and Operations Research (55 citations) and Economics and Econometrics (92 citations). DA Berry has collaborated with scholars based in United States. Frequent co-authors include NM Hylton, L. Esserman, Kelloff Gj, Mehra Golshan, LA Carey, George Somlo, EP Winer, Bhupender Singh, Deborah Collyar and August J. Salvado. Their work appears in journals such as Cancer Research and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.